Intelligence Platform
Patents
Browse 68 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12186363
Compositions and methods for dengue virus chimeric constructions in vaccines
granted patentUS 12152242
CRISPR therapy
granted patentUS 11986534
Treatment of anthrax with pegylated capsule-degrading enzyme
granted patentUS 11959096
Methods for selective inhibition of pluripotent stem cells
granted patentUS 11878064
Nanoparticle/peptide method of blocking potassium channels
granted patentUS 11865172
Materials and methods for respiratory disease control in canines
granted patentUS 11786601
Pegylated capsule-degrading enzyme for the treatment of anthrax
granted patentUS 11746335
Development of dengue virus vaccine components
granted patentUS 11744834
Metal-porphyrin complexes for the inactivation of the biological activity of opioids
granted patentUS 11739137
Single domain antibodies to SARS-CoV-2 nucleocapsid protein
granted patentUS 11617800
Nanoparticle-enhanced activity of a potassium channel-blocking peptide
granted patentUS 11542320
Nucleic acids encoding single domain antibodies to chikungunya virus
granted patentUS 11497803
Modulation of replicative fitness by deoptimization of synonymous codons
granted patentUS 11471528
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to
granted patentUS 11339387
Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 prec
granted patentUS 11332722
Development of dengue virus vaccine components
granted patentUS 11191824
Method of purifying virus-like-particles
granted patentUS 11160859
Materials and methods for respiratory disease control in canines
granted patentUS 11154608
Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominan
granted patentUS 11045558
RPGR gene therapy for retinitis pigmentosa
granted patentUS 11041008
Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia
granted patentUS 11028152
Single domain antibodies to Chikungunya virus
granted patentUS 11008564
Processing engineered FMDV P1 polypeptide using an alternative TEV protease
granted patentUS 10934360
Human monoclonal antibodies against EPHA4 and their use
granted